Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€24.44
14.01.22
-
14.01.23
-10.19%
22.01.22

Risky Investment
buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€4.08
08.01.22
€6.00
08.01.23
-26.40%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€123.30
17.08.21
-
17.08.22
-27.01%
12.01.22

buy
Mediclin AG

Start price
Target price
Perf. (%)
€4.36
10.01.21
€6.00
10.01.22
-15.14%
11.01.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
4 SC AG

Start price
Target price
Perf. (%)
€2.11
10.01.21
€2.00
10.01.22
-29.15%
11.01.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Top 10 in its market
Known brand
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€183.96
17.12.21
€240.00
17.12.22
-37.46%
10.01.22

Could be worthwhile Investment >10% per year
Some uniques
buy
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€1.15
27.12.21
-
27.12.22
-18.26%
10.01.22

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€134.44
30.12.21
-
30.12.22
-13.81%
09.01.22

Risky Investment
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€33.72
03.01.22
-
03.01.23
-14.00%
09.01.22

Risky Investment
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.54
03.01.22
-
03.01.23
-14.69%
09.01.22

Risky Investment
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.88
20.12.21
€1.20
20.12.22
-25.64%
09.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.35
26.12.21
-
26.12.22
-7.81%
09.01.22

Risky Investment
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.58
21.08.21
€220.00
21.08.22
-13.54%
08.01.22

Revenue growth >5% per year expected
Undervalued
Probably not worthwhile Investment
Lower EBIT Margin than peer group
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€147.98
05.12.21
-
05.12.22
-23.17%
07.01.22

Could be worthwhile Investment >10% per year
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.92
28.07.21
-
28.07.22
-25.00%
06.01.22

Probably not worthwhile Investment
High valuation
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€10.05
05.01.21
-
05.01.22
-68.70%
06.01.22

Could be worthwhile Investment >10% per year
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€10.20
01.01.21
€7.00
01.01.22
-66.98%
02.01.22

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
High Investments for future growth
buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.60
12.12.21
-
12.12.22
23.60%
25.12.21

Could be very worthwhile Investment >20% year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€3.32
12.12.21
-
12.12.22
2.65%
25.12.21

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year